Biomet Microfixation is a global medical device company specializing in the design and manufacture of state of the art, clinically proven products. Biomet is an innovative leader in creating real solutions in the areas of craniomaxillofacial, neuro and thoracic implants and devices, whether that solution requires a minimally-invasive surgical technique, advanced biomaterials, or a patient-matched implant. Our technologies are enhancing and changing the quality of patients' lives today and in the future.
Established in 1977, Biomet is a family of companies that has enjoyed steady growth at levels exceeding market expansion. Biomet's performance demonstrates a responsive, customer-oriented approach to the health care market. Biomet thrives by strengthening its commitment to innovation and partnership.
Biomet prides itself on its unconventional profile: the responsiveness and innovation of a small company, with the resources and market presence of a large company.
Biomet, Inc. and its subsidiaries design, manufacture, and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet’s product portfolio encompasses reconstructive products, including orthopedic joint replacement devices, bone cements and accessories, autologous therapies and dental reconstructive implants; fixation products, including electrical bone growth stimulators, internal and external orthopedic fixation devices, craniomaxillofacial implants and bone substitute materials; spinal products, including spinal stimulation devices, spinal hardware and orthobiologics; and other products, such as arthroscopy products and softgoods and bracing products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.